Frequency of Cardiac Amyloidosis in the Caribbean's. (TEAM Amylose)

• Register: ClinicalTrials.gov
• Last refreshed on: 16 December 2017
• Main ID: NCT03322319
• Date of registration: 23/10/2017
• Prospective Registration: No
• Primary sponsor: University Hospital Center of Martinique
• Public title: Frequency of Cardiac Amyloidosis in the Caribbean's. (TEAM Amylose)
• Scientific title: acTive scrEening of cArdiac aMyloidosis in the Caribbean's
• Date of first enrolment: September 23, 2013
• Target sample size: 175
• Recruitment status: Completed
• URL: https://clinicaltrials.gov/show/NCT03322319
• Study type: Interventional
• Study design: Intervention model: Single Group Assignment. Primary purpose: Diagnostic. Masking: None (Open Label).
• Phase: N/A

Countries of recruitment

Guadeloupe, Martinique

Contacts

• Name: Jocelyn INAMO, MD-PhD
• Affiliation: Centre Hospitalier Universitaire de Martinique, France

Key inclusion & exclusion criteria

Inclusion Criteria:

- Age > 18 years,

- Residency in French Caribbean Regions

- Access to healthcare coverage,

- Written informed consent obtained

Exclusion Criteria:

- Evidence of another cause for left ventricular hypertrophy (uncontrolled severe high
blood pressure, untreated severe aortic stenosis, family history of hypertrophic
cardiomyopathy)

- Inability to deliver informed consent,

- Presence of a known severe disease impending participation in the study



Age minimum: 18 Years
Age maximum: N/A
Gender: All

Health Condition(s) or Problem(s) studied

Left Ventricular Hypertrophy

Intervention(s)

Procedure: Tissue biopsies

Primary Outcome(s)

Diagnosis of cardiac amyloidosis. [Time Frame: 3 months]

Secondary Outcome(s)

Subtyping of cardiac amyloidosis [Time Frame: 2 years]

Secondary ID(s)

12/B/17

Source(s) of Monetary Support

Please refer to primary and secondary sponsors